ATOS Atossa Therapeutics, Inc.

Fundamentals / CIK 0001488039 / USD

Atossa Therapeutics, Inc. reported $26.45M in total assets and a net loss of $34.66M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ATOS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$0$0$0-$32.51MFY 2016 Net Income: -$6.37M2016FY 2017 Net Income: -$8.12M2017FY 2018 Net Income: -$11.40M2018FY 2019 Net Income: -$17.24M2019FY 2020 Net Income: -$17.83M2020FY 2021 Net Income: -$20.61M2021FY 2022 Net Income: -$26.96M2022FY 2023 Net Income: -$30.09M2023FY 2024 Net Income: -$25.50M2024FY 2025 Net Income: -$34.77M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $21.18M $14.12M $17.33M $15.08M $9.21M $6.61M $6.65M $4.21M $2.33M $770K
Total Operating Expenses $37.14M $27.62M $31.38M $27.69M $20.52M $14.61M $17.27M $11.43M $7.65M $7.97M
Operating Income -$37.14M -$27.62M -$31.38M -$27.69M -$20.52M -$14.61M -$17.27M -$11.43M -$7.65M -$7.97M
EBITDA -$37.12M -$27.60M -$31.35M -$27.68M -$20.50M -$14.56M -$17.21M -$11.39M -$7.52M -$7.67M
Interest Income $2.38M $4.05M $4.34M $877K $6.0K -- -- -- -- --
Income Before Tax -$34.77M -$25.50M -$30.09M -$26.96M -$20.61M -$17.83M -$17.24M -$11.40M -$8.12M -$6.37M
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0 $0 --
Net Income -$34.77M -$25.50M -$30.09M -$26.96M -$20.61M -$17.83M -$17.24M -$11.40M -$8.12M -$6.37M
Basic EPS -$4.04 -$3.04 -$3.60 -$3.15 -$2.70 -$29.55 -$30.45 -$82.50 -$164.55 -$32.40
Diluted EPS -$4.04 -$3.04 -$3.60 -$3.15 -$2.70 -$29.55 -$30.45 -$82.50 -$164.55 -$32.40
Basic Shares Outstanding 8.6M 8.4M 8.4M 8.4M 7.8M 754 566.5K 277.2K 65.0K 196.5K
Diluted Shares Outstanding 8.6M 8.4M 8.4M 8.4M 7.8K 754 566.5K 277.2K 65.0K 196.5K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $3.38M $4.90M $4.78M $6.16M $5.37M $5.50M $4.16M $3.40M
Total Operating Expenses $5.90M $8.69M $9.87M $11.44M $9.25M $9.04M $7.41M $7.15M
Operating Income -$5.90M -$8.69M -$9.87M -$11.44M -$9.25M -$9.04M -$7.41M -$7.15M
EBITDA -$5.89M -$8.69M -$9.87M -$11.43M -$9.25M -$9.04M -$7.41M -$7.15M
Interest Income $209K $227K $309K $442K $570K $645K $720K $837K
Income Before Tax -$5.64M -$8.49M -$9.59M -$10.94M -$8.69M -$8.42M -$6.72M -$6.35M
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$5.64M -$8.49M -$9.59M -$10.94M -$8.69M -$8.42M -$6.72M -$6.35M
Basic EPS -$0.56 -$0.95 -$1.11 -- -$1.01 -$0.98 -$0.78 --
Diluted EPS -$0.56 -$0.95 -$1.11 -- -$1.01 -$0.98 -$0.78 --
Basic Shares Outstanding 10.0M 8.9M 8.6M -- 8.6M 8.6M 8.6M --
Diluted Shares Outstanding 10.0M 8.9M 8.6M -- 8.6M 8.6M 8.6M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $41.30M $71.08M $88.46M $110.9M $136.4M $39.55M $12.58M $10.38M $7.22M $3.03M
Cash & Short-Term Investments $41.30M $71.08M $88.46M $110.9M $136.4M $39.55M $12.58M $10.38M $7.22M $3.03M
Other Current Assets -- -- -- $2.42M $1.19M $657K $26K $31K $16K --
Total Current Assets $45.62M $74.46M $92.22M $118.2M $141.2M $42.77M $14.32M $11.55M $7.90M $3.25M
Property, Plant & Equipment, Net -- -- -- -- $20K $21K $34K $54K $11K $55K
Intangible Assets -- -- -- -- $54K $41K $174K $192K $234K $640K
Other Non-Current Assets $1.99M $1.99M $2.32M $635K $22K $17K $17K $17K $179K $194K
Total Non-Current Assets $1.99M $1.99M $4.03M $5.33M $22K $69K $171K $171K $266K $890K
Total Assets $47.61M $76.44M $96.25M $123.5M $141.3M $42.84M $14.49M $11.72M $8.16M $4.14M
Accounts Payable $4.29M $679K $806K $2.96M $1.72M $1.59M $293K $353K $335K $254K
Other Current Liabilities $1.10M $1.51M $1.80M $19K $21K $4.0K $13K $40K $16K $6.1K
Total Current Liabilities $8.26M $4.97M $5.24M $5.57M $3.13M $15.67M $1.32M $2.92M $1.23M $1.05M
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $11K $0 $0 $0
Total Liabilities $8.26M $4.97M $5.24M $5.57M $3.13M $15.67M $1.33M $2.92M $1.23M $1.05M
Total Debt (incl. Leases) -- -- -- -- -- $18K $50K -- -- --
Common Stock $1.55M $1.55M $22.79M $22.79M $22.79M $8.56M $1.64M $1.05M $477K $57K
Retained Earnings -$246.6M -$211.8M -$186.3M -$156.2M -$129.2M -$111.9M -$94.07M -$76.83M -$65.43M -$57.30M
Accumulated Other Comp. Income -- -- -- -- $0 -- -- -- -- --
Total Stockholders' Equity $39.35M $71.48M $91.02M $118.0M $138.1M $27.17M $13.16M $8.81M $6.94M $3.10M
Total Equity $39.35M $71.48M $91.02M $118.0M $138.1M $27.17M $13.16M $8.81M $6.94M $3.10M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $20.57M $26.09M $31.72M $41.30M $51.84M $57.86M $65.12M $71.08M
Cash & Short-Term Investments $20.57M $26.09M $31.72M $41.30M $51.84M $57.86M $65.12M $71.08M
Total Current Assets $25.18M $31.01M $36.67M $45.62M $55.68M $62.52M $68.74M $74.46M
Other Non-Current Assets $1.27M $1.27M $1.27M $1.99M $2.33M $2.00M $2.00M $1.99M
Total Non-Current Assets $1.27M $1.27M $1.27M $1.99M $2.33M $2.00M $2.00M $1.99M
Total Assets $26.45M $32.28M $37.94M $47.61M $58.01M $64.52M $70.75M $76.44M
Accounts Payable $1.50M $1.98M $2.57M $4.29M $3.54M $2.01M $1.17M $679K
Other Current Liabilities $745K $1.12M $1.14M $1.10M $1.57M $1.56M $1.53M $1.51M
Total Current Liabilities $4.71M $5.45M $7.46M $8.26M $8.22M $6.82M $5.42M $4.97M
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $4.71M $5.45M $7.46M $8.26M $8.22M $6.82M $5.42M $4.97M
Common Stock $1.80M $1.80M $1.55M $1.55M $23.49M $23.49M $23.49M $1.55M
Retained Earnings -$270.3M -$264.6M -$256.2M -$246.6M -$235.6M -$226.9M -$218.5M -$211.8M
Total Stockholders' Equity $21.74M $26.83M $30.49M $39.35M $49.79M $57.70M $65.32M $71.48M
Total Equity $21.74M $26.83M $30.49M $39.35M $49.79M $57.70M $65.32M $71.48M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$34.77M -$25.50M -$30.09M -$26.96M -$20.61M -$17.83M -$17.24M -$11.40M -$8.12M -$6.37M
Depreciation & Amortization $16K $17K $23K $8.0K $23K $47K $53K $44K $129K $303K
Stock-Based Compensation $2.65M $2.29M $4.62M $6.79M $5.27M $3.02M $7.10M $1.05M $787K $876K
Change in Payables $3.61M -$127K -$2.16M $1.25M $128K $1.29M -$60K $18K $81K -$560K
Operating Cash Flow -$29.76M -$21.03M -$20.94M -$20.76M -$16.47M -$11.57M -$9.13M -$8.96M -$6.59M -$5.37M
Capital Expenditure -$23K -$19K -$14K -$27K -$9.0K -$9.0K -$7.6K -$111K -- --
Free Cash Flow -$29.79M -$21.05M -$20.95M -$20.79M -$16.48M -$11.58M -$9.14M -$9.07M -- --
Investing Cash Flow -$23K -$19K -$14K -$4.73M -$9.0K -$9.0K -$7.6K -$111K -- -$9.2K
Common Stock Issued -- -- -- -- $113.5M -- -- -- $6.16M $4.70M
Share Repurchases -- $0 -$1.48M $0 -- -- -- -- -- --
Financing Cash Flow $0 $3.67M -$1.48M $0 $113.3M $38.55M $11.34M $12.29M $10.78M $4.70M
Net Change in Cash -$29.79M -$17.38M -$22.43M -$25.49M $96.82M $26.97M $2.20M $3.22M $4.19M -$688K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$5.64M -$8.49M -$9.59M -$10.94M -$8.69M -$8.42M -$6.72M -$6.35M
Depreciation & Amortization $4.0K $4.0K $4.0K $4.0K $4.0K $4.0K $4.0K $4.0K
Stock-Based Compensation $547K $815K $722K $503K $784K $796K $563K $774K
Change in Payables -$475K -$593K -$1.72M $761K $1.52M $845K $486K -$882K
Operating Cash Flow -$5.52M -$9.64M -$9.58M -$10.54M -$6.00M -$7.26M -$5.96M -$7.05M
Capital Expenditure $0 $0 $0 -$7.0K -$7.0K $0 -$9.0K $0
Free Cash Flow -$5.52M -$9.64M -$9.58M -$10.55M -$6.01M -$7.26M -$5.97M -$7.05M
Investing Cash Flow $0 $0 $0 -$7.0K -$7.0K $0 -$9.0K $0
Financing Cash Flow $0 $4.02M $0 $0 $0 $0 $0 $3.37M
Net Change in Cash -$5.52M -$5.62M -$9.58M -$10.55M -$6.01M -$7.26M -$5.97M -$3.68M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -88.4% -35.7% -33.1% -22.9% -14.9% -65.6% -131.0% -129.5% -117.1% -205.6%
Return on Assets (ROA) -73.0% -33.4% -31.3% -21.8% -14.6% -41.6% -119.0% -97.3% -99.5% -153.7%
Current Ratio 5.53x 14.99x 17.61x 21.23x 45.18x 2.73x 10.83x 3.96x 6.45x 3.11x
Quick Ratio 5.00x 14.31x 16.89x 19.92x 43.63x 2.52x 9.51x 3.56x 5.89x 2.89x
Debt to Equity -- -- -- -- -- 0.00x 0.00x -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -159.4% -140.5% -123.5% -88.4% -60.6% -49.8% -40.3% -35.7%
Return on Assets (ROA) -131.0% -116.8% -99.2% -73.0% -52.0% -44.5% -37.2% -33.4%
Current Ratio 5.35x 5.69x 4.92x 5.53x 6.77x 9.17x 12.67x 14.99x
Quick Ratio 4.37x 4.79x 4.25x 5.00x 6.30x 8.48x 12.00x 14.31x
Source: SEC EDGAR CompanyFacts (CIK 0001488039) · from December 31, 2010 Data through September 30, 2026 · synced Nov 21, 2026, 05:03 UTC · Open in terminal